title: The in vivo availability of gentamicin when admixed with total nutrient solutions: a comparative study.
abstract: The relative in vivo availability of gentamicin when administered by two different intravenous methods was evaluated in patients treated in a surgical intensive care unit in a randomized, prospective, crossover study. Each patient received gentamicin therapy via intravenous piggyback (IVPB) and in-line burette (ILB) methods. In the IVPB method, the drug was mixed in 5% dextrose in water (D5W) and infused intermittently. In the ILB method, the drug was mixed using the patient's total nutrient admixture (TNA) solution as the diluent in an ILB, which was inserted between the TNA bottle and its administration set and infused intermittently. A serial sampling of four sets of serum concentrations of the gentamicin was obtained. Pharmacokinetic parameters (Kel, Vd, and a maximum serum concentration) were calculated from the four sets of concentrations collected per patient. The IVPB method yielded mean values of Kel, Vd, and C1.5mg/kg of 0.13 hr-1, 0.39 liter/kg, and 5.1 micrograms/ml, respectively. The ILB method yielded mean values of Kel, Vd, and C1.5mg/kg of 0.14 hr-1, 0.34 liter/kg, and 5.6 micrograms/ml, respectively. A t-test for paired samples was applied to these mean values. Significant difference was not found (p greater than 0.05). The intermittent infusion of gentamicin, using TNA as the diluent and an ILB, produced equivalent serum concentrations when compared with D5W as the diluent.
authors.affiliation: School of Pharmacy, University of Southern California, Los Angeles 90033.
authors.forename: J W
authors.initials: JW
authors.lastname: Kern
authors.forename: K J
authors.initials: KJ
authors.lastname: Lee
authors.forename: J T
authors.initials: JT
authors.lastname: Martinoff
authors.forename: H
authors.initials: H
authors.lastname: Silberman
mesh_terms: D000368:Aged; D001682:Biological Availability; D005260:Female; D005526:Food, Formulated / Q000009:adverse effects; D005839:Gentamicins / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D010289:Parenteral Nutrition, Total / Q000009:adverse effects; D011446:Prospective Studies
chemical_list: D005839:Gentamicins